Organization | HumanN

HumanN Report issue

For profit Phase 2

Founded: Austin TX United States (2009)

Status: No NME R&D (2009)

Organization Overview

First Clinical Trial

2012

NCT01710761

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2017

Timeline

NOW

Now

Alternative names

HumanN | Neogenis Laboratories

Active Ingredients

Drugs in Phase 2 Trials (4)

cyanocobalamin (berocca) (2 trials)

hawthorn berry extract (2 trials)

nitric oxide (inomax) (3 trials)

vitamin c (3 trials)

Drugs in Other Trials (5)

caffeine (1 trial)

cobalamin (1 trial)

crataegus extract (1 trial)

n5-carbamoylornithine (1 trial)

nitric acid (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Hypertension (Phase 2)

Prehypertension (Phase 2)

Overview

Highest Phase: Phase 2
# of Trials: 7
# of Trial APIs: 9